TrialCancer communications (London, England)2018

Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study.

Jung Hoon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.